相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Generic Atorvastatin and Health Care Costs
Cynthia A. Jackevicius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Validation of candidate genes associated with cardiovascular risk factors in psychiatric patients
Andreas Windemuth et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Mechanisms of statin-induced myalgia assessed by physiogenomic associations
Gualberto Ruano et al.
ATHEROSCLEROSIS (2011)
Paraoxonase-1 is a major determinant of clopidogrel efficacy
Heleen J. Bouman et al.
NATURE MEDICINE (2011)
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis
Jessica L. Mega et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Warfarin Genotyping Reduces Hospitalization Rates Results From the MM-WES (Medco-Mayo Warfarin Effectiveness Study)
Robert S. Epstein et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA Boxed Warning A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association
David R. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice
Felix W. Frueh
PHARMACOGENOMICS (2010)
Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?
Gualberto Ruano et al.
PHARMACOGENOMICS (2010)
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Frederick G. Kushner et al.
CIRCULATION (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pharmacogenetics in Europe: Barriers and Opportunities
D. Gurwitz et al.
PUBLIC HEALTH GENOMICS (2009)
Physiogenomic association of statin-related myalgia to serotonin receptors
Gualberto Ruano et al.
MUSCLE & NERVE (2007)
Aspirin and clopidogrel resistance: an emerging clinical entity
TH Wang et al.
EUROPEAN HEART JOURNAL (2006)
Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle homeostasis
G Ruaño et al.
PHARMACOGENOMICS (2005)
Clopidogrel for coronary stenting - Response variability, drug resistance, and the effect of pretreatment platelet reactivity
PA Gurbel et al.
CIRCULATION (2003)
分享论文
